Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03511664
Title Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer (VISION)
Acronym VISION
Recruitment Completed
Gender male
Phase Phase III
Variant Requirements No
Sponsors Endocyte
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | SWE | NLD | GBR | FRA | DNK | DEU | CAN | BEL


No variant requirements are available.